7 results
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Antiplatelet Conversion ... Drug interactions ... #switching #conversion ... ticagrelor #prasugrel #pharmacology ... #Cangrelor
Antiplatelet Conversion - P2Y12 Inhibitor Switching
 • Clopidogrel (Plavix)
 • Prasugrel (Effient)
 • Ticagrelor (Brilinta)
Clopidogrel and
Antiplatelet Conversion ... Switching • Clopidogrel ... that bind to the active ... #Switching #pharmacology ... #cardiology
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... Oral P2Y12 Inhibitors ... dose of a given drug ... #switching #conversion ... ticagrelor #prasugrel #pharmacology
Pharmaceutical Management of Hyperthyroidism / Thyroid Storm
Beta-Blockers 
• Decreases sympathetic hyperactivity 
• Partially blocks peripheral conversion
• Decreases conversion ... Faster onset of action ... Teratogenic Iodine • Inhibits ... ThyroidStorm #Management #Pharmacology ... #Medications #Drugs
Cangrelor - Pharmacology
Cangrelor (Kengreal) is a parenteral analogue of adenosine triphosphate
Cangrelor binds reversibly to the platelet
Cangrelor - Pharmacology ... an oral P2Y12 inhibitor ... effects - These active ... such that the drug ... #Kengreal #Pharmacology
Medications Used in Congestive Heart Failure

In CHF, the heart is failing as a pump; cardiac output
failure is chronic Drug ... chronic CHF aims to inhibit ... #Pharmacology #CHF ... #Medications #Action ... #HeartFailure #Cardiology
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
Cardiovascular Drug-Drug ... - Potentiates action ... - Potentiates action ... supplementals #herbal #pharmacology ... #DDI #table #cardiology